Use of M-M-R II outside of the routinely recommended age range – a systematic literature review

M-M-R®(II) (M-M-R II) is routinely used in many countries at 12–15 months with a second dose at 4 to 6 years of age. However, the vaccine may need to be administered at other ages due to delays in the immunization schedule or in certain situations such as outbreaks or international travel. A systema...

Descripción completa

Detalles Bibliográficos
Autores principales: Pawaskar, Manjiri, Schmidt, Elvira, Marshall, Gary S., Fergie, Jaime, Richardson, Elizabeth, Saldutti, Louise Parks, Li, Se, Neumann, Monika, Koller, Linnea, Kuter, Barbara
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2021
Materias:
Licensed Vaccines – Short Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8920138/
https://www.ncbi.nlm.nih.gov/pubmed/34128759
http://dx.doi.org/10.1080/21645515.2021.1933874

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8920138/
https://www.ncbi.nlm.nih.gov/pubmed/34128759
http://dx.doi.org/10.1080/21645515.2021.1933874

Ejemplares similares